ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1465–1476 of 2020 project topics
Von Willebrand Factor VWF Gene Mutation Detection Platform
A cloud-based diagnostic platform that sequences and analyzes VWF gene variants to identify type 1, 2, and 3 von Willebrand disease with clinical-grade accuracy. This SaaS solution enables laboratories to automate bleeding disorder diagnosis, reducing turnaround time from weeks to days while capturing recurring subscription revenue from healthcare providers.
Genetic Basis of Bleeding Diathesis Click to view more details →
Factor V Leiden F5 Gene Thrombophilia Risk Stratification Tool
An AI-powered predictive analytics tool that genotypes F5 mutations and correlates thrombotic risk with patient demographics and medication profiles for personalized anticoagulation planning. The platform monetizes through per-test licensing fees and premium subscription tiers for integrated electronic health record systems in hospital networks.
Genetic Basis of Bleeding Diathesis Click to view more details →
Prothrombin F2 Gene Variant Screening Commercial Laboratory Service
A CLIA-certified reference laboratory service that performs high-throughput F2 gene variant analysis and delivers comprehensive reports to clinicians and direct-to-consumer clients. The business generates revenue through per-sample testing fees, volume discounts for healthcare systems, and premium urgent-turnaround service tiers.
Genetic Basis of Bleeding Diathesis Click to view more details →
Factor VIII FVIII Gene Hemophilia A Mutation Database SaaS
A proprietary cloud-based mutation database and interpretation engine that catalogs FVIII variants, predicts protein function impact, and guides carrier screening and treatment selection for hemophilia A patients. The platform generates recurring revenue through institutional subscriptions, per-analysis API calls, and pharma partnerships for gene therapy patient stratification.
Genetic Basis of Bleeding Diathesis Click to view more details →
Factor IX FIX Gene Hemophilia B Carrier Detection Commercial Kit
A next-generation sequencing assay kit and accompanying cloud data analysis portal that identifies FIX gene mutations in hemophilia B families for reproductive risk counseling and family planning. This consumable product generates high-margin recurring revenue through bulk orders from genetic testing laboratories, maternal-fetal medicine clinics, and preventive care networks.
Genetic Basis of Bleeding Diathesis Click to view more details →
Fibrinogen FGB FGA Gene Dysfibrinogenemia Phenotype Prediction Engine
An advanced machine learning platform that analyzes FGB and FGA gene variants and predicts functional fibrinogen defects to stratify bleeding severity and guide clotting factor replacement therapy. The solution monetizes through laboratory software licensing, integration partnerships with bleeding disorder registries, and consulting services for pharmaceutical companies developing fibrinogen therapies.
Genetic Basis of Bleeding Diathesis Click to view more details →
PMM2-CDG Molecular Diagnosis and Counseling
Characterizing PMM2 pathogenic variants causing the most common CDG for molecular diagnosis, genotype-phenotype correlation, and genetic counseling.
Genetic Basis of Congenital Disorders of Glycosylation Click to view more details →
CDG Next Generation Sequencing Panel Development
Developing comprehensive CDG gene panels covering N-glycosylation, O-glycosylation, and GPI anchor pathway genes for molecular CDG diagnosis.
Genetic Basis of Congenital Disorders of Glycosylation Click to view more details →
Biochemical-Genetic Correlation in CDG
Correlating transferrin isoelectric focusing patterns and glycan mass spectrometry with causative gene mutations for CDG diagnostic pathway optimization.
Genetic Basis of Congenital Disorders of Glycosylation Click to view more details →
Novel CDG Gene Discovery by WES
Using whole exome sequencing for identifying novel glycosylation pathway gene mutations in CDG patients with atypical biochemical profiles.
Genetic Basis of Congenital Disorders of Glycosylation Click to view more details →
CDG Carrier Screening SaaS Platform for Reproductive Planning
A cloud-based diagnostic platform integrating carrier screening algorithms and risk stratification tools for couples planning pregnancies with CDG family histories. This service generates recurring revenue through subscription licensing to fertility clinics, reproductive medicine centers, and genetic counseling facilities worldwide.
Genetic Basis of Congenital Disorders of Glycosylation Click to view more details →
Automated CDG Protein Glycosylation Biomarker Analysis Tool
A software tool that automatically quantifies aberrant N-linked and O-linked glycosylation patterns from mass spectrometry data to enable rapid CDG subtype classification. The platform creates commercial value by reducing diagnostic turnaround time and enabling laboratory automation, supporting high-throughput CDG screening in clinical diagnostics companies.
Genetic Basis of Congenital Disorders of Glycosylation Click to view more details →